C. diff. Spores and More

Join us with our guest Joe Martin, Executive Director of a Pennsylvania Health Care organization. Mr. Martin has more than 30 years of experience in the public relations field, including public, government and media relations, policy development, and non-profit fundraising for various organizations. Mr. Martin will be discussing C. difficile infections and Hospital Admissions through the years. He has been widely quoted in the academic, health care, and popular press internationally, in the US, and throughout Pennsylvania to discuss health care data and reports.

Join us with our guests, Lisa Hurka-Covington, Kathy Bischoff, Renetta Dudinski, and Veronica Edmond all C. diff. Survivors sharing their personal journey and road to recovery from a C. difficile infection. Nothing resonates more than the words shared from an individual who has been diagnosed, treated, and has recovered from this infection and other wellness-draining illnesses. If you have any questions for any of our guests, e-mail them to [email protected] and we look forward to answering them on the live broadcast.

Join us with our guest Dr. Arjun Srinivasan, an Infectious Disease Doctor and the Associate Director of Healthcare Associated Infection Prevention Programs for the Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention in Atlanta, Georgia -- as we introduce Healthcare Associated Infections and discuss the progress being made to prevent them and the goals in place to eliminate HAI's.

Join us with our guest Dr. Arjun Srinivasan, an Infectious Disease Doctor and the Associate Director of Healthcare Associated Infection Prevention Programs for the Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention in Atlanta, Georgia -- as we introduce Healthcare Associated Infections and discuss the progress being made to prevent them and the goals in place to eliminate HAI's.

Join Us With Guest Dr. Richard Vickers, Ph.D., Chief Scientific Officer at Summit Therapeutics joining us to discuss their research on a new antibiotic to treat a C. difficile infection. Learn more about Ridinilazole, clinical trials and the progress being made and moving closer to getting an urgently needed new treatment available for CDI to patients.

Join us as guests Sue Barnes, RN, BSN, CIC, FAPIC, Independent and Board Certified Clinical Consultant in Infection Control and Prevention and APIC Fellow with Lori Strazdas, MPH - Public Health Liaison with Clorox Healthcare discuss the importance of C. difficile and how difficult of an infection it is to manage not only for patients but for the caretakers and loved ones. Before the patient leaves the hospitals, it is critical to understand the proper steps to reduce the spread of C. difficile spores in the home environment. In this episode, learn why it is important to focus on the home environment during and after a C. difficile infection and what can be done to reduce the risk of transmission and recurrence. Our guests will be discussing the types of disinfecting products that can be utilized to effectively kill C. diff. spores and how to use the products properly to accomplish this in the home environment.

Join us with our guests Bruce Rippe, CEO of Trinity Guardion and J. Darrel Hicks, BA, Master REH, CHESP as we discuss HAIs and how they lead to more than 720,000 illnesses and 75,000 deaths a year. In fact, more people die from HAIs each year than from automobile accidents. Furthermore, HAIs are a huge financial burden, adding $30 billion to annual healthcare costs. The American-made Trinity Patient Protection System gives hospitals the solution they need to reduce and eliminate HAIs. Launderable, reusable, cost-effective and eco-friendly, the Trinity System’s fluid-proof covers fit around beds, pillows, stretchers and physical therapy tables. Unlike typical disinfectant agents designed for hard surfaces, the Trinity System keeps bacteria off the porous surface of the mattress, as well as, the bed deck. When laundered to CDC standards, the Trinity System removes 99.99% of bacteria and has been proven to reduce C. diff infection rates by about 50%.

Join us with our guest, Dr Mary Beth Dorr, PhD, Clinical Director, Clinical Research, Infectious Diseases,

Merck & Co., Inc. as Mary Beth provides us with an overview of a C. diff. infection, the challenges of recurrence, latest clinical research overview, current treatment landscape, and pending new C. diff infection treatment guidelines from the Infectious Diseases Society of America (IDSA) that are anticipated to come out this fall.

Join us with our guests, Lisa Hurka-Covington, Kathy Bischoff, Renetta Dudinski, and Veronica Edmond all C. diff. Survivors sharing their personal journey and road to recovery from a C. difficile infection. Nothing resonates more than the words shared from an individual who has been diagnosed, treated, and has recovered from this infection and other wellness-draining illnesses. If you have any questions for any of our guests, e-mail them to [email protected] and we look forward to answering them on the live broadcast.

Richard Haupt, MD, Vice President, Medical Development Scientific & Clinical Affairs, at Pfizer where he serves as the global franchise lead for pipeline vaccines and Kathrin U. Jansen, PhD, Senior Vice President and head of Vaccine Research and Development at Pfizer Inc and Chris Webber, MD, Senior Director, Vaccines Clinical Research and Development. Dr. Webber is clinical program lead of the recently acquired meningococcal ACWY program from GSK, and is the clinical program lead for Pfizer’s Clostridium difficile vaccine. Our discussion will be focused on C. difficile Prevention: Evaluating the Role of Vaccines.